US 10758598
TPP-1 formulations and methods for treating CLN2 disease
granted A61KA61K38/4813A61K47/02
Quick answer
US patent 10758598 (TPP-1 formulations and methods for treating CLN2 disease) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOMARIN PHARMACEUTICAL INC.
- Grant date
- Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/4813, A61K47/02, A61K9/0048, A61K9/0085